UK markets close in 7 hours 21 minutes

CV Sciences, Inc. (0HRT.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
0.0850-0.0150 (-15.00%)
As of 07:01PM BST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.60
52-week change 3-18.50%
S&P500 52-week change 325.69%
52-week high 30.0450
52-week low 30.0000
50-day moving average 30.0389
200-day moving average 30.0389

Share statistics

Avg vol (3-month) 37.45k
Avg vol (10-day) 37.84k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 8163.2M
% held by insiders 10.02%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -20.38%
Operating margin (ttm)-15.49%

Management effectiveness

Return on assets (ttm)-17.38%
Return on equity (ttm)-87.25%

Income statement

Revenue (ttm)15.86M
Revenue per share (ttm)0.10
Quarterly revenue growth (yoy)-3.50%
Gross profit (ttm)N/A
EBITDA -2.53M
Net income avi to common (ttm)-3.23M
Diluted EPS (ttm)-0.1330
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)662k
Total cash per share (mrq)0
Total debt (mrq)274k
Total debt/equity (mrq)11.60%
Current ratio (mrq)1.23
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)760k
Levered free cash flow (ttm)1.27M